Journal of Oncology

Angiogenesis and Tumor Metastasis


Publishing date
01 Aug 2022
Status
Published
Submission deadline
25 Mar 2022

Lead Editor

1First Affiliated Hospital of Hebei North University, Zhangjiakou, China

2Sun Yat-sen University, Guangzhou, China

3University of California, San Francisco, USA


Angiogenesis and Tumor Metastasis

Description

The growth, invasion, and metastasis of malignant tumors require the formation of neovascularization. Tumor angiogenesis requires activation and proliferation of endothelial cells, degradation of the basement membrane, and extension of endothelial cells outwards in a cable shape. In addition, tumor angiogenesis is also mediated by multiple vascular growth factors and vascular growth inhibition factors. The angiogenesis of tumor metastasis has complex molecular mechanisms.

However, the in-depth regulatory mechanism of tumor angiogenesis and its role in tumor metastasis remain to be further studied and reported. Tumors grow slowly by having no blood vessels to provide a blood supply. Tumor cells then release a variety of angiogenic factors that alter the original morphology of vascular endothelial cells. The basement membrane and extracellular matrix are degraded, and endothelial cells proliferate and migrate, forming and remodeling blood vessels. At present, anti-angiogenesis has become one of the new methods to treat tumors. In conclusion, the process of tumor progression and metastasis is extremely complex. Tumor metastasis is caused by the mutual regulation and interaction of many aspects, many stages, and many molecules.

We welcome original submissions and review articles to this Special Issue with the aim to develop understanding in this field. In-depth understanding of the molecular mechanisms of angiogenesis in tumor metastasis would be helpful to lay a solid molecular biological foundation for the clinical treatment of tumor metastasis. It also opens up a new milestone for the comprehensive treatment of tumors.

Potential topics include but are not limited to the following:

  • Tumor vasculogenic mimicry
  • Regulation mechanism of tumor angiogenesis
  • Mechanism study of anti-tumor angiogenesis drugs
  • Review on the progress of anti-tumor angiogenesis drugs
  • The role of non-coding RNA in tumor angiogenesis and vascular metastasis
  • The role of traditional chinese medicine molecules in inhibiting tumor angiogenesis and hematologic metastasis
  • Regulation mechanism of tumor angiogenesis factors

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 1303748
  • - Research Article

The Effects of circ_000558/miR-1225-5p/ARL4C on Regulating the Proliferation of Renal Cell Carcinoma Cells

Ling Xia | Minghuan Ge | ... | Yue Xia
  • Special Issue
  • - Volume 2022
  • - Article ID 9778555
  • - Research Article

Prognostic Nomogram of Osteocarcinoma after Surgical Treatment

Qiuli Wu | Canchun Yang | ... | Bo Li
  • Special Issue
  • - Volume 2022
  • - Article ID 3382360
  • - Research Article

Global Trends in Research of Treatment on Bladder Cancer with Chinese Medicine Monomer from 2000 to 2021: A Bibliometric Analysis

Desheng Li | Minfang Zuo | Xinming Hu
  • Special Issue
  • - Volume 2022
  • - Article ID 5308577
  • - Research Article

Hesperidin Inhibits the p53-MDMXInteraction-Induced Apoptosis of Non-Small-Cell Lung Cancer and Enhances the Antitumor Effect of Carboplatin

Yu Feng | Hongjie Huo | Qiong Tang
  • Special Issue
  • - Volume 2022
  • - Article ID 3684228
  • - Research Article

Global Trends in Research of NF-κB in Melanoma from 2000 to 2021: A Study of Bibliometric Analysis

Jun Wang | Xuan Liao | ... | Hongwei Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 7498771
  • - Research Article

Paeoniflorin Inhibits the Proliferation and Metastasis of Ulcerative Colitis-Associated Colon Cancer by Targeting EGFL7

Yunxia Wang | Yi Zhou | ... | Shu Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 8762647
  • - Research Article

Efficacy of Trastuzumab + Cisplatin Combined with Irinotecan on the Quality of Life of Patients with Advanced Her-2 Positive Gastric Cancer

Yu-Xin Yang | Chun-Ying Li | ... | Xia Chen
  • Special Issue
  • - Volume 2022
  • - Article ID 8100323
  • - Research Article

Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial

Weiping Li | Zhigang Cao | ... | Dehui Chang
  • Special Issue
  • - Volume 2022
  • - Article ID 9356807
  • - Review Article

The Exosome Journey: From Biogenesis to Regulation and Function in Cancers

Yuan Li | Li Meng | ... | Baobing Zhao
  • Special Issue
  • - Volume 2022
  • - Article ID 9082501
  • - Research Article

Effects of Docetaxel plus Degarelix on Quality of Life and Vascular Endothelial Growth Factor in Patients with Prostate Cancer

Weiping Li | Dongbo Xu | ... | Bin Zhang
Journal of Oncology
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision136 days
Acceptance to publication68 days
CiteScore3.900
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.